Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation
Top Cited Papers
- 22 March 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (3), 402-406
- https://doi.org/10.1016/j.jcf.2021.03.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutationJournal of Cystic Fibrosis, 2018
- Pregnancy among cystic fibrosis women in the era of CFTR modulatorsJournal of Cystic Fibrosis, 2017
- A Case Report of Pregnancy During Use of Targeted Therapeutics for Cystic FibrosisJournal of Obstetric, Gynecologic & Neonatal Nursing, 2016
- Attitudes and Decision Making Related to Pregnancy Among Young Women with Cystic FibrosisMaternal and Child Health Journal, 2016
- Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis*The Journal of Maternal-Fetal & Neonatal Medicine, 2016
- A successful uncomplicated CF pregnancy while remaining on IvacaftorJournal of Cystic Fibrosis, 2016
- Potential impact on fertility of new systemic therapies for cystic fibrosisPaediatric Respiratory Reviews, 2015
- Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesisWorld Journal of Diabetes, 2015
- Pregnancy and cystic fibrosis: Approach to contemporary managementObstetric Medicine, 2014
- Cystic fibrosis and fertilityCurrent Opinion in Obstetrics and Gynecology, 2013